APHA
Back to Annual Meeting Page
 
American Public Health Association
133rd Annual Meeting & Exposition
December 10-14, 2005
Philadelphia, PA
APHA 2005
 
Session: Injecting Drug Use and HIV: Findings from Research and Practice
3245.0: Monday, December 12, 2005: 2:30 PM-3:30 PM
Poster
Injecting Drug Use and HIV: Findings from Research and Practice
This session presents findings from research and practice on the intersecting epidemics of drug use and HIV/AIDS.
Learning Objectives: At the conclusion of the session, participants will be able to: 1) List the major communities for whom drug use and HIV are most relevant. 2) Delineate innovative programming for drug-using individuals. 3) Identify nexts steps in the prevention, care, and treatment of HIV/AIDS among drug users.
Moderator(s):Tania Basta, MPH
Board 1Characteristics of high-risk social networks and social support among young adult non-injecting heroin, crack and cocaine users in New York City
Crystal Fuller, MPH, PhD, Bernadette R. Hadden, PhD, Qi Xia, Carl A. Latkin, PhD, Danielle C. Ompad, PhD, Daniel J. Pilowsky, MD, MPH
Board 2Social network characteristics associated with use of pharmacies as a syringe source among IDUs in New York City: Implications for social network-based interventions
Crystal Fuller, PhD, Wendy Caceres, BA, Sandro Galea, MD, MPH, Shannon Blaney, MPH, Danielle C. Ompad, PhD, David Vlahov, PhD
Board 3Social and political predictors associated with the presence of syringe exchange programs in 96 metropolitan areas in the US
Barbara Tempalski, MA, MPH, Peter L. Flom, PhD, Samuel R. Friedman, PhD, Don C. Des Jarlais, PhD, Courtney McKnight, MPH, Risa Friedman, MPH, Judith J. Friedman, PhD
Board 4Association between drug treatment use, mental health status, and needle sharing among injection drug users
Lena M. Lundgren, PhD, Maryann Amodeo, PhD, Deborah Chassler, MSW, Linsey Ben-Ami, MPH
Board 5HIV/HCV risk reduction intervention for young incarcerated IDUs
Patricia M. Morse, PhD, Edward V. Morse, PhD
Board 6Are syringe exchange programs (SEPs) giving out enough syringes to lower HIV risk? Examining the association between distributed syringes, injection frequencies and HIV risk among clients of California SEPs
Ricky N. Bluthenthal, PhD, Lauren Gee, Mary Lou Gilbert, JD, MA, Rachel Anderson, BA, Neil Flynn, MD, MPH, Andrea Scott, Alexander H. Kral, PhD
Board 7Interventions to increase self-efficacy and self-esteem and reduce HIV/HCV risk among young incarcerated IDUs
Edward V. Morse, PhD, Patricia M. Morse, PhD
Board 8A comparison of sex risk for HIV/STI infection among young injecting and non-injecting heroin users
Alan Neaigus, PhD, V. Anna Gyarmathy, PhD, MS, MPH, Maureen Miller, PhD, Veronica M. Frajzyngier, MPH
Board 9Assessment of New York's Expanded Syringe Access Demonstration Program: Results from statewide baseline and follow-up surveys of pharmacies
James M. Tesoriero, PhD, Haven B. Battles, PhD, Karyn K. Heavner, MSPH, Nakeshia Knight-Coyle, MSW, Guthrie Birkhead, MD, MPH, Susan J. Klein, MS
Board 10Differences in HIV-related injection risk behaviors among Puerto Rican drug users who initiated drug use in Puerto Rico versus New York
Sung-Yeon Kang, PhD, Sherry Deren, PhD, Hector M. Colón, PhD, Rafaela Robles, EdD
See individual abstracts for presenting author's disclosure statement and author's information.
Organized by:HIV/AIDS
Endorsed by:Community Health Planning and Policy Development; Epidemiology; Maternal and Child Health; Socialist Caucus

The 133rd Annual Meeting & Exposition (December 10-14, 2005) of APHA